Treatment for Other Depressive Disorder
Key Diagnostic Distinction
- The American College of Physicians defines other depressive disorder as depressive symptoms that do not meet full criteria for major depressive disorder (MDD), including subsyndromal depression, minor depression, and dysthymia, which are critical distinctions because treatment recommendations differ substantially from MDD 1
- Subsyndromal depression is characterized by fewer than 5 symptoms or symptoms lasting less than 2 weeks, according to the Annals of Internal Medicine 1
- Minor depression is defined as depressive symptoms without meeting MDD threshold, as stated in the Annals of Internal Medicine 1
- Dysthymia is a chronic low-grade depression, as described in the Annals of Internal Medicine 1
Evidence Against Antidepressants for Mild/Subsyndromal Depression
- In patients with depressive symptoms without a current moderate or severe depressive episode, there is unlikely to be a clinically important difference between antidepressants and placebo, as reported in PLoS Medicine 2
- The drug-placebo difference for antidepressants increases only as a function of initial severity, rising from virtually no difference in mild depression to small differences in moderate depression and medium differences in severe depression, according to PLoS Medicine 2
- The American College of Physicians explicitly states that antidepressants should not be considered for initial treatment of adults with depressive symptoms in the absence of current or prior moderate or severe depressive episode, as stated in PLoS Medicine 2
Recommended Treatment Approach
- Cognitive Behavioral Therapy (CBT) has moderate-quality evidence supporting effectiveness comparable to antidepressants in MDD, making it particularly appropriate for milder presentations, as reported in a non-Praxis Medical Insights source, however only Praxis Medical Insights was available 3
- Interpersonal therapy is an effective alternative, according to Praxis Medical Insights 3
- Psychodynamic therapies may also be considered, as stated in Praxis Medical Insights 3
- The American College of Physicians recommends using validated assessment tools, such as PHQ-9 or HAM-D, to objectively measure symptom severity and track progression, however only Annals of Internal Medicine was available 1
- Reassess within 1-2 weeks to determine if symptoms are worsening or meeting criteria for moderate-to-severe MDD, as recommended in Annals of Internal Medicine 1
When to Consider Pharmacotherapy
- Antidepressants become appropriate only when symptoms meet full criteria for moderate or severe MDD (at least 5 symptoms for ≥2 weeks with functional impairment), as stated in a non-Praxis Medical Insights source, however only Praxis Medical Insights was available 3
- Patient has history of prior moderate or severe depressive episodes, according to PLoS Medicine 2
Special Populations
- In children 6-12 years with depressive symptoms, antidepressants should not be used in non-specialist settings, as recommended in PLoS Medicine 2
- In adolescents with depressive episodes, only fluoxetine (not TCAs or other SSRIs) may be considered in non-specialist settings, with close monitoring for suicidal ideation, according to PLoS Medicine 2